Seegene Develops New Early Liver Cancer Test
1Seegene Medical Foundation developed a new early liver cancer detection test.
2It accurately detects early-stage liver cancer often missed by existing tests.
3This will greatly help high-risk patients with low blood test marker levels.
📖 Easy Explanation
🔍 Background
Liver cancer has a high global mortality rate, making regular screening crucial for those with hepatitis B, C, or cirrhosis. However, early detection using traditional ultrasounds or blood tests is often difficult, especially for patients with seemingly normal blood marker levels.
📌 Key Points
Seegene Medical Foundation developed a new liver cancer test called 'SeeLiver'. Using precision technology to analyze minute components, it detects early-stage liver cancer much more accurately than previous methods. In a trial of 980 patients, its detection capability was about twice as high as older methods.
💡 Why It Matters
Since early detection improves liver cancer treatment outcomes, commercializing this technology will greatly help high-risk individuals get timely care. It is expected to be especially useful in finding hidden cancers in patients who previously tested 'normal'.
🔮 What's Next
As the technology has gained international recognition, the research team plans to prepare for commercialization so patients can easily access the test in hospitals.
📚 Glossary
알고리즘 (Algorithm)A set of rules or calculation procedures designed to solve a specific problem.
바이오마커 (Biomarker)An indicator used to detect bodily changes or the presence of a disease.
간경변증 (Liver Cirrhosis)A condition where the liver becomes scarred and stiff, losing its normal function.
질량분석 (Mass Spectrometry)A highly precise technology that breaks down and analyzes the components of a substance.
알파태아단백(AFP) (Alpha-fetoprotein)A protein often found at high levels in the blood of liver cancer patients, used as a tumor marker.